Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due toEnterobacteriaceae(SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial